- Home
- QNCX vs GAN Comparison
QNCX vs GAN Comparison
Compare QNCX & GAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- GAN
- Stock Information
- Founded
- QNCX 2012
- GAN 1999
- Country
- QNCX United States
- GAN United States
- Employees
- QNCX N/A
- GAN N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- GAN Computer Software: Programming Data Processing
- Sector
- QNCX Health Care
- GAN Technology
- Exchange
- QNCX Nasdaq
- GAN Nasdaq
- Market Cap
- QNCX 92.3M
- GAN 83.2M
- IPO Year
- QNCX 2019
- GAN 2020
- Fundamental
- Price
- QNCX $1.60
- GAN $1.89
- Analyst Decision
- QNCX Strong Buy
- GAN
- Analyst Count
- QNCX 4
- GAN 0
- Target Price
- QNCX $9.50
- GAN N/A
- AVG Volume (30 Days)
- QNCX 147.1K
- GAN 192.3K
- Earning Date
- QNCX 11-13-2024
- GAN 03-12-2025
- Dividend Yield
- QNCX N/A
- GAN N/A
- EPS Growth
- QNCX N/A
- GAN N/A
- EPS
- QNCX N/A
- GAN N/A
- Revenue
- QNCX N/A
- GAN $134,024,000.00
- Revenue This Year
- QNCX N/A
- GAN $5.97
- Revenue Next Year
- QNCX N/A
- GAN $11.32
- P/E Ratio
- QNCX N/A
- GAN N/A
- Revenue Growth
- QNCX N/A
- GAN N/A
- 52 Week Low
- QNCX $0.51
- GAN $1.17
- 52 Week High
- QNCX $2.45
- GAN $1.89
- Technical
- Relative Strength Index (RSI)
- QNCX 42.75
- GAN 66.27
- Support Level
- QNCX $1.40
- GAN $1.86
- Resistance Level
- QNCX $1.79
- GAN $1.85
- Average True Range (ATR)
- QNCX 0.15
- GAN 0.03
- MACD
- QNCX -0.02
- GAN 0.00
- Stochastic Oscillator
- QNCX 32.79
- GAN 100.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.
About GAN GAN Limited
GAN Ltd provides Software-as-a-Service solutions for online casino gaming and sports betting applications. The company has two operating segments B2B and B2C. The B2B segment develops, markets, and sells instances of GameSTACK, GAN Sports, and iSight Back Office technology that incorporates comprehensive player registration, account funding, and back-office accounting and management tools that enable the casino operators to efficiently, confidently, and effectively extend their presence online in places that have permitted online real money gaming, and The B2C segment, which includes the operations of Coolbet, develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada.